The majority of fungal infections are caused by species such as Candida and Aspergillus. Other rare and emerging opportunistic fungal infections are on the increase. Risk factors for such infections include receipt of antimicrobial agents, chemotherapy, immunosuppression secondary to hematopoietic stem cell or solid organ transplantation, neutropenia, presence of indwelling intravascular catheter, prior hemodialysis, or previous fungal colonization. We present here the first 2 reports of fatal and invasive Chaetomium infections in pediatric patients. The first case occurred in a child with acute myeloid leukemia (AML) and the other in a child with hemophagocytic syndrome (HSP)
Objective: Fungal infection is a significant problem, causing of infective deaths of leukemic patien...
Saprochaeta Capitata is an emerging fungus known to cause life-threatening infections in immunocompr...
PubMed ID: 26275731Empirical antifungal therapy is most often given to patients with leukemia. Howev...
Bone marrow transplant recipients are highly susceptible to opportunistic fungal infections. This is...
Although the outcome of childhood leukemia and severe aplastic anemia (SAA) has improved, infectious...
The incidence of invasive fungal infections (IFIs) has dramatically increased over the last few deca...
<p>Worldwide distribution of mold fungi and their extremely danger for immune compromise patients ma...
Invasive fungal infections (IFI) are an important cause of mortality and morbidity in patients with ...
Background: Invasive fungal infection (IFI) causes significant morbidity and mortality in patients w...
Background.: Although a number of risk factors have been associated with invasive fungal disease (IF...
Invasive fungal infections in children with acute lymphoblastic leukemia have been a major cause of ...
Invasive fungal infections remain a life threatening complication in children with hematological mal...
Invasive fungal infection (IFI) is a cause of morbidity, mortality and increased health costs in chi...
AbstractEmpirical antifungal therapy is most often given to patients with leukemia. However breakthr...
Objective: The incidence of invasive fungal infections (IFIs) has increased due to intensive chemoth...
Objective: Fungal infection is a significant problem, causing of infective deaths of leukemic patien...
Saprochaeta Capitata is an emerging fungus known to cause life-threatening infections in immunocompr...
PubMed ID: 26275731Empirical antifungal therapy is most often given to patients with leukemia. Howev...
Bone marrow transplant recipients are highly susceptible to opportunistic fungal infections. This is...
Although the outcome of childhood leukemia and severe aplastic anemia (SAA) has improved, infectious...
The incidence of invasive fungal infections (IFIs) has dramatically increased over the last few deca...
<p>Worldwide distribution of mold fungi and their extremely danger for immune compromise patients ma...
Invasive fungal infections (IFI) are an important cause of mortality and morbidity in patients with ...
Background: Invasive fungal infection (IFI) causes significant morbidity and mortality in patients w...
Background.: Although a number of risk factors have been associated with invasive fungal disease (IF...
Invasive fungal infections in children with acute lymphoblastic leukemia have been a major cause of ...
Invasive fungal infections remain a life threatening complication in children with hematological mal...
Invasive fungal infection (IFI) is a cause of morbidity, mortality and increased health costs in chi...
AbstractEmpirical antifungal therapy is most often given to patients with leukemia. However breakthr...
Objective: The incidence of invasive fungal infections (IFIs) has increased due to intensive chemoth...
Objective: Fungal infection is a significant problem, causing of infective deaths of leukemic patien...
Saprochaeta Capitata is an emerging fungus known to cause life-threatening infections in immunocompr...
PubMed ID: 26275731Empirical antifungal therapy is most often given to patients with leukemia. Howev...